Royalty Pharma plc
$49.47
$0.62(-1.24%)
Royalty Pharma plc
RPRX
$49.47
$0.62(-1.24%)
Royalty Pharma plc
RPRX
NASDAQ
$49.47
$0.62(-1.24%)
Chart
Upcoming Earnings
Next report date
May 6, 2026
Report period
Q2 2026
EPS Estimate
$1.22
Revenue Estimate
$881.69M
Key stats
52-Week Range$49.47
$31.97
$50.82
Market capitalization
$21.61BDividend yield (indicated)
1.81%Price to earnings Ratio (TTM)
27.71Basic EPS (TTM)
$1.95Net income (TTM)
$770.95MRevenue (TTM)
$2.38BAvg. volume
3.31MBeta (1Y)
0.39Employees
75Market capitalization
$21.61BDividend yield (indicated)
1.81%Price to earnings Ratio (TTM)
27.71Basic EPS (TTM)
$1.95Net income (TTM)
$770.95MRevenue (TTM)
$2.38BAvg. volume
3.31MBeta (1Y)
0.39Employees
75Screener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Royalty Pharma plc
Sector
Healthcare
Industry
Biotechnology
CEO
Pablo Legorreta
Website
www.royaltypharma.comHeadquarters
110 East 59th Street, New York City, NY, 10022
IPO Date
2020-06-16
Identifiers
ISIN
GB00BMVP7Y09Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in...
Related Stocks
$572.20
1D:
-1.6%
1Y:
91.6%
US91307C1027Healthcare
Mkt Cap
$25.08B
P/E Ratio TTM
18.9
Revenue TTM
$3.18B
Beta
0.75
Earnings TTM
$1.33B
Dividend Yield TTM
0.00%
$28.32
1D:
-0.1%
1Y:
144.8%
BMG762791017Healthcare
Mkt Cap
$20.27B
P/E Ratio TTM
-24.0
Revenue TTM
$13.31M
Beta
1.21
Earnings TTM
$-809.24M
Dividend Yield TTM
0.00%
Dividend Overview
Dividend yield (indicated)
1.81%
Dividend per share
$0.90annual
Payout ratio (Earnings)
49.1%
Payout ratio (FCF)
15.5%
Dividend growth streak
0
Dividend CAGR (3Y)
-16.3%
Dividend CAGR (5Y)
-7.1%
Dividend CAGR (10Y)
—
Dividend yield (indicated)
1.81%
Dividend per share
$0.90annual
Payout ratio (Earnings)
49.1%
Payout ratio (FCF)
15.5%
Dividend growth streak
0
Dividend CAGR (3Y)
-16.3%
Dividend CAGR (5Y)
-7.1%
Dividend CAGR (10Y)
—
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate